Compounds > 2,6-diaminopurine
Page last updated: 2024-08-23

2,6-diaminopurine and Benign Neoplasms

2,6-diaminopurine has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BERGER, RE; BIESELE, JJ; ELION, GB; HITCHINGS, GH; WILSON, AY1
BURCHENAL, JH; CRAVER, LF; DARGEON, HW; ESCHER, GC; KARNOFSKY, DA; KINGSLEY-PILLERS, EM; MYERS, WP; RHOADS, CP; SOUTHAM, CM1

Other Studies

2 other study(ies) available for 2,6-diaminopurine and Benign Neoplasms

ArticleYear
Studies on 2,6-diaminopurine and related substances in cultures of embryonic and sarcomatous rodent tissues.
    Cancer, 1951, Volume: 4, Issue:1

    Topics: 2-Aminopurine; Humans; Neoplasms; Purines; Sarcoma

1951
The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease, with special reference to acute leukemia.
    Cancer, 1951, Volume: 4, Issue:3

    Topics: 2-Aminopurine; Folic Acid Antagonists; Leukemia; Neoplasms; Purines

1951